⌘K
Loading ticker…
As of 2026-08-24, Supernus Pharmaceuticals, Inc. (SUPN) has a 3-month relative strength percentile of 35 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 47. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.7%, relative volume 0.47×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
SUPN is in a stage 1 base, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -3.4% / -7.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
SUPN appears in 1 ETF as of Jun 2026: PSC at 0.13% weight, $3M notional.
Held by 113 ETFs · $752M across latest filings · largest weight 4.46% (PSIL).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.13% | $3M | −0.05 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SUPN Jan avg: 3.41% median: 1.51% win: 50% σ: 9.01% n: 4 2022-04-12 → 2026-07-31 | SUPN Feb avg: -0.96% median: -0.52% win: 50% σ: 13.85% n: 4 2022-04-12 → 2026-07-31 | SUPN Mar avg: 1.96% median: -0.73% win: 50% σ: 9.20% n: 4 2022-04-12 → 2026-07-31 | SUPN Apr avg: -6.07% median: -7.14% win: 20% σ: 6.36% n: 5 2022-04-12 → 2026-07-31 | SUPN May avg: -5.26% median: -3.79% win: 0% σ: 4.52% n: 5 2022-04-12 → 2026-07-31 | SUPN Jun avg: -1.35% median: -0.57% win: 40% σ: 4.85% n: 5 2022-04-12 → 2026-07-31 | SUPN Jul avg: 6.13% median: 9.79% win: 80% σ: 6.87% n: 5 2022-04-12 → 2026-07-31 | SUPN Aug avg: 14.50% median: 12.86% win: 100% σ: 11.09% n: 4 2022-04-12 → 2026-07-31 (current) | SUPN Sep avg: -4.98% median: -6.21% win: 25% σ: 9.04% n: 4 2022-04-12 → 2026-07-31 | SUPN Oct avg: 3.09% median: 5.25% win: 75% σ: 12.48% n: 4 2022-04-12 → 2026-07-31 | SUPN Nov avg: 2.86% median: 7.24% win: 75% σ: 13.84% n: 4 2022-04-12 → 2026-07-31 | SUPN Dec avg: 2.81% median: 2.54% win: 50% σ: 5.70% n: 4 2022-04-12 → 2026-07-31 |